BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//SciLifeLab - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.scilifelab.se
X-WR-CALDESC:Events for SciLifeLab
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Stockholm
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20201025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20211031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20221030T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20210923T080000
DTEND;TZID=Europe/Stockholm:20210924T170000
DTSTAMP:20260404T183112
CREATED:20210628T112516Z
LAST-MODIFIED:20210628T112631Z
UID:10000402-1632384000-1632502800@www.scilifelab.se
SUMMARY:Annual Symposium on ATP1A3 in Disease
DESCRIPTION:Sweden is a child-friendly country with long traditions in pediatric care and research. We will introduce some new aspects in AHC and ATP1A3 related disease that should open up for new research projects and new therapeutic strategies. \n\n\n\nPreliminary\, our main themes will be: \n\n\n\nThe origin of gait disturbances;The origin and recording of pain;The lipid environment of the ATP1A3 molecule\n\n\n\nThe 9th Annual Symposium was originally planned to take place in October 2020\, but due to the current pandemic we unfortunately had to postpone the meeting. Detailed planning of the 2021 Symposium in Stockholm is ongoing and updates will continually be announced on this website. \n\n\n\nIn our time of Covid-19 pandemic\, we can assure possibility for social distancing in our conference venue\, Aula Medica of Karolinska Institutet Campus Solna. The main hall is approximated for up to 1\,000 persons\, and will give plenty of space for our symposium which is planned for 100-120 persons. \n\n\n\nPlease stay tuned and stay safe! \n\n\n\nOn behalf of the Organizing committee \n\n\n\nAnita Aperia      Eli Gunnarson     Hjalmar Brismar
URL:https://www.scilifelab.se/event/annual-symposium-on-atp1a3-in-disease/
LOCATION:Aula Medica\, Nobels väg 6\, Solna
CATEGORIES:Event
ATTACH;FMTTYPE=image/png:https://www.scilifelab.se/wp-content/uploads/2021/06/atp21-logo-sept-1200-2.png
ORGANIZER;CN="Akademikonferens":MAILTO:ATP1A3-2021@akademikonferens.se
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20210924T080000
DTEND;TZID=Europe/Stockholm:20210924T170000
DTSTAMP:20260404T183112
CREATED:20210908T125241Z
LAST-MODIFIED:20220330T154121Z
UID:10000441-1632470400-1632502800@www.scilifelab.se
SUMMARY:Researcher’s Night at SciLifeLab
DESCRIPTION:The European Researchers’ Night is a Europe-wide public event\, which displays the diversity of science and its impact on citizens’ daily lives in fun\, inspiring ways. This year\, the event will take place in 29 countries on Friday 24 September 2021. \n\n\n\nThe European Researchers’ Night aims to \n\n\n\nbring research and researchers closer to the publicpromote excellent research projects across Europe and beyondincrease the interest of young people in science and research careersshowcase the impact of researchers’ work on people’s daily lives\n\n\n\nIn Sweden\, activities will be organised across the country and online under the name ForskarFredag (Researchers’ Friday) coordinated by the Swedish nonprofit organisation Vetenskap & Allmänhet \n\n\n\nOpen to schools and individuals from all of over Sweden. Please register at Vetenskapens hus’ website to receive the zoom-link. \n\n\n\nRead more and register\n\n\n\nSciLifeLab will participate in Researcher’s night as part of Vetenskapens Hus program\, with a set of lectures orchestrated by the Public Engagement Committee. We invite participants from schools all over Sweden to tune in to interesting lectures by our researchers. The lectures are given in English\, are 15 minutes long and are followed by the opportunity for discussion with the researcher for another 15 minutes. They cover varying topics such as how spaceflight affect astronauts’ bodies and how different microscopical techniques can be used to study the cellular world. \n\n\n\n \n\n\n\n09:00How does spaceflight affect astronauts’ bodies?Stefania Giacomello\, KTH10:00Is weight-loss surgery properly restoring insulin response?Carsten Daub\, Karolinska Institutet/SciLifeLab11:00Cellular world observed with microscopy – in two partsErdinc Sezgin\, Karolinska Institutet/SciLifeLab\, Marta Carroni\, Stockholm University/SciLifeLab14:00Hidden treasure: an immunological master switch deep in our gutsLuisa Hugerth\, Karolinska Institutet/SciLifeLab15:00Sex differences in the immune systemCamila Rosat Consiglio\, Karolinska Institutet/SciLifeLab
URL:https://www.scilifelab.se/event/researchers-night-at-scilifelab/
LOCATION:Online event via Zoom
CATEGORIES:Event
ATTACH;FMTTYPE=image/png:https://www.scilifelab.se/wp-content/uploads/2021/09/Forskarfredag.png
ORGANIZER;CN="SciLifeLab Event":MAILTO:events@scilifelab.se
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20210924T080000
DTEND;TZID=Europe/Stockholm:20210924T170000
DTSTAMP:20260404T183112
CREATED:20240909T095320Z
LAST-MODIFIED:20240925T074739Z
UID:10001349-1632470400-1632502800@www.scilifelab.se
SUMMARY:Researcher’s Night at SciLifeLab
DESCRIPTION:The European Researchers’ Night is a Europe-wide public event\, which displays the diversity of science and its impact on citizens’ daily lives in fun\, inspiring ways.  \n\n\n\nThe European Researchers’ Night aims to \n\n\n\n\nbring research and researchers closer to the public\n\n\n\npromote excellent research projects across Europe and beyond\n\n\n\nincrease the interest of young people in science and research careers\n\n\n\nshowcase the impact of researchers’ work on people’s daily lives\n\n\n\n\nIn Sweden\, activities will be organised across the country and online under the name ForskarFredag (Researchers’ Friday) coordinated by the Swedish nonprofit organisation Vetenskap & Allmänhet \n\n\n\nRead more and register\n\n\n\n\n\nForskarfredag SciLifeLab 2024Download
URL:https://www.scilifelab.se/event/researchers-night-at-scilifelab-2/
LOCATION:Air&Fire\, SciLifeLab Stockholm\, Tomtebodavägen 23A\, Solna\, Sweden
CATEGORIES:Event
ATTACH;FMTTYPE=image/png:https://www.scilifelab.se/wp-content/uploads/2021/09/Forskarfredag.png
ORGANIZER;CN="SciLifeLab Event":MAILTO:events@scilifelab.se
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20210928T151500
DTEND;TZID=Europe/Stockholm:20210928T163000
DTSTAMP:20260404T183112
CREATED:20210923T094943Z
LAST-MODIFIED:20210923T122525Z
UID:10000453-1632842100-1632846600@www.scilifelab.se
SUMMARY:The Svedberg seminar series: Prof. Ana Pombo
DESCRIPTION:MDC Berlin Institute for Medical Systems Biology (BIMSB) \, Humboldt University\, Germany \n\n\n\nLINK TO SEMINAR \n\n\n\n\n\n\n\n\n\nAna Pombo investigates mechanisms that regulate 3D genome folding and gene expression during mammalian  development and in disease. After her doctorate work at the University of Oxford (UK)\, Ana was a recipient of a Royal Society Dorothy Hodgkin Fellowship. She started her independent group in 2000\, at the MRC London Institute for Medical Sciences\, Imperial College London\, before moving to the Max Delbrueck Center for Molecular Medicine in Berlin\, in Germany. Ana received the Robert Feulgen Prize in 2007\, and was elected EMBO member in 2018. She is a Professor at the Humboldt University of Berlin and the Deputy Scientific Directed of the Berlin Institute for Medical Systems Biology at MDC. \n\n\n\nFunctional specialization of 3D genome structures in brain cell types\n\n\n\nDuring lineage commitment\, cells sustain cascades of gene activation and repression to generate specific cell types that execute specialized functions. To investigate the variability of the 3D conformation of the genome in different cell types and their relation with cell-type specific patterns of gene expression\, we applied Genome Architecture Mapping is specific brain cell types from the adult murine brain\, without disturbing their native tissue environment: dopaminergic neurons (DNs) from the midbrain\, pyramidal glutamatergic neurons (PGNs) from the hippocampus\, and oligodendrocyte lineage cells (OLGs) from the cortex. We find extensive reorganization of genome topology\, which the reorganization of topological domains\, chromatin compartments and specific long-range hubs of contacts between neuron-specific genes. We also discover events of extensive chromatin decondensation\, or ‘melting’\, at long neuronal genes when they are highly transcribed\, many of them associated with neurodevelopmental disorders or neurodegeneration. Our work shows that the 3D organization of the genome is highly specific of cell type and strongly related with gene expression programs.Read more about Ana Pombo`s research: https://www.mdc-berlin.de/pomboHost:  Eva Brinkman\, KI
URL:https://www.scilifelab.se/event/the-svedberg-seminar-series-prof-ana-pombo/
LOCATION:Online event via Zoom
CATEGORIES:Event
ORGANIZER;CN="The Svedberg Seminar Series":MAILTO:thesvedberg@scilifelab.uu.se
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20210930T130000
DTEND;TZID=Europe/Stockholm:20210930T150000
DTSTAMP:20260404T183112
CREATED:20210924T134253Z
LAST-MODIFIED:20210924T134331Z
UID:10000454-1633006800-1633014000@www.scilifelab.se
SUMMARY:SuperResolutionMiniSymposia
DESCRIPTION:13:00-13:50 Accessing the nanoscale with MINFLUXFrancisco Balzarotti (IMP Vienna)Topic: new super resolution light microscopy method to image proteins and DNA with 1 nm spatial resolution.Of interest for the imaging and biophysics community \n\n\n\n14-14:50Imaging more labels using ’smart’ probes and PSF engineeringPeter Dedecker (Leuven University)Topic: multiplexing light microscopy with smart probes and optical development. \n\n\n\n \n\n\n\nHybrid Meeting – Join in Air&Fire or Join Zoom Meeting: \n\n\n\nhttps://kth-se.zoom.us/j/61036958775?pwd=VVpXVmJDQUFzVCttR2FaNFY2Nm9zQT09Meeting ID: 610 3695 8775Password: 028016
URL:https://www.scilifelab.se/event/superresolutionminisymposia/
LOCATION:Air&Fire\, SciLifeLab Stockholm\, Tomtebodavägen 23A\, Solna\, Sweden
CATEGORIES:Event
ORGANIZER;CN="Ilaria Testa":MAILTO:ilaria.testa@scilifelab.se
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20210930T170000
DTEND;TZID=Europe/Stockholm:20210930T173000
DTSTAMP:20260404T183112
CREATED:20210908T154652Z
LAST-MODIFIED:20210910T122137Z
UID:10000442-1633021200-1633023000@www.scilifelab.se
SUMMARY:Clinical Talks: Detect cancer early\, while it still can be cured
DESCRIPTION:On September 30\, Dr. Hyunsung John Kim\, will talk about the amazing potential RNA liquid biopsies can offer modern healthcare\, by detecting cancer early\, while it still can be cured. Resulting in a total transformation of cancer care\, ultimately allowing for a more efficient\, cost-effective\, and sustainable healthcare. While working as a senior Bioinformatician at Illumina\, John was part of the founding team who branched out GRAIL\, with its very promising Galleri multi-cancer early detection test soon to hit our Clinical reality.  \n\n\n\nRegister to receive zoom link\n\n\n\n\n\n\n\nJohn develops cloud computing tools that use machine learning and AI to generate biological insights from large clinically relevant datasets. He has worked in Next Generation Sequencing (NGS) and bioinformatics for over ten years in academic and industrial settings. \n\n\n\nHe started his career at the University of California at Santa Cruz where he received the Chancellor’s fellowship for designing new sequencing assays and algorithms for diagnostics and immunology. After receiving his PhD in Bioinformatics and Biomolecular Engineering\, John joined the Advanced Research group at Illumina. There he played a critical role in launching Illumina’s single cell product by developing the accompanying cloud-based bioinformatics software and was given the CEO award for his contributions. \n\n\n\nJohn departed from Illumina to make a significant impact on the fight against cancer by joining GRAIL Inc. as one of its founding members. At GRAIL\, he led a team of data scientists\, software engineers and statisticians as a bioinformatics technical lead. His team worked to gain a better understanding cell free nucleic acids and develop diagnostic products that detect cancer earlier than the current standard of care. John holds multiple patents and was an author on the first patent awarded to GRAIL. In addition\, he has co-authored peer-reviewed publications on his work related to the early cancer detection from cell free nucleic acids. \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nClinical Talks Series\n\n\n\nAfter our recent planning hiatus\, we now have the great pleasure to announce that “Clinical Talks” has been renewed for yet another exciting\, innovative\, and enlightening season. This season will focus on sustainable innovations within Life Sciences\, that have the potential to contribute to a better climate friendly future for our future generations. Also new this year is that the seminar is co-organized in a collaboration between SciLifeLab and KI Innovations. \n\n\n\nRead more about the clinical talk series here\n\n\n\nSeason 5\, will be held September until December 2021 with a total of seven scheduled Talks\, during Friday mornings 09-09:30 am via ZOOM (with some time-zone friendly adjustments for our international speakers). Each session consists of a talk given by our invited speaker followed by Q&A. The seminar is an open educational seminar series for our ever-expanding Life Science community.
URL:https://www.scilifelab.se/event/clinical-talks-detect-cancer-early-while-it-still-can-be-cured/
LOCATION:Online event via Zoom
CATEGORIES:Event
ATTACH;FMTTYPE=image/jpeg:https://www.scilifelab.se/wp-content/uploads/2021/09/ClinicalTalks_Season5_twitter_1024.jpg
ORGANIZER;CN="Clinical Talks":MAILTO:precisionmedicine@scilifelab.se
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20211001T090000
DTEND;TZID=Europe/Stockholm:20211001T110000
DTSTAMP:20260404T183112
CREATED:20210902T060431Z
LAST-MODIFIED:20210902T060444Z
UID:10000424-1633078800-1633086000@www.scilifelab.se
SUMMARY:BioImage Informatics Call4Help
DESCRIPTION:Every 1st week of the month (mainly on Tuesdays\, but there might be exceptions) the BioImage Informatics Facility together with microscopy expert Sylvie Le Guyader (LCI\, Karolinska Institutet) organizes a Call4Help session. The aim is to offer combined expertise towards microscopy and bioimage analysis. All researchers from Swedish institutes can participate. \n\n\n\nThe ideal timepoint to join the Call4Help session is when a researcher has performed pilot experiments and has tried out first analysis approaches – but before having recorded hundreds of images. Combining BIIF’s expertise in BioImage Analysis with microscopy expertise we can discuss ways to record the images that allow analysis afterwards. We will discuss different analysis approaches using mainly open-source software (Fiji\, CellProfiler\, QuPath\, Ilastik\, KNIME)\, but also commercial systems\, if needed (Imaris). \n\n\n\nThe Call4Help session format has been introduced to the BioImage Analysis community by NEUBIAS and ScopeM. \n\n\n\nHow to participate? \n\n\n\nStep1: \n\n\n\nPrepare a short presentation (5-7 min)  – use the following template for your presentation: \n\n\n\nhttp://bit.ly/BIIF_C4H_slideTemplate \n\n\n\nSlide template by NEUBIAS/ScopeM \n\n\n\nStep2: \n\n\n\na) Upload your presentation \n\n\n\nUpload your presentation to a drive of your choice. You can also use our Call4Help google drive. Note that files shared on our Call4Help drive will be available to everyone until the session is over. \n\n\n\nhttp://bit.ly/BIIF_C4H_Drive \n\n\n\nb) Upload example images for testing. \n\n\n\nUpload example images for testing either to the drive of your choice or our Call4Help google drive above. \n\n\n\nhttp://bit.ly/BIIF_C4H_Drive \n\n\n\nc) Register by filling out the registration form: \n\n\n\nhttp://bit.ly/BIIF_C4H_Registration \n\n\n\nStep 3: \n\n\n\nJoin the zoom-session. \n\n\n\nIf your problem is selected for presentation\, you will get a time-slot of 30 – 60 minutes within the session. \n\n\n\nWhat are the Deadlines \n\n\n\nSubmission of a problem and upload of example data: Deadline for application: Tuesday\, September 28\, 2021. \n\n\n\nNotification about participation: The day before the session. \n\n\n\nNext Call4Help session \n\n\n\nFriday\, October 1\, 2021\, 9.00-12.00. Deadline for application: Tuesday\, September 28\, 2021.
URL:https://www.scilifelab.se/event/bioimage-informatics-call4help-4/
CATEGORIES:Event
ORGANIZER;CN="Bioimage Informatics Unit":MAILTO:biif@scilifelab.se
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20211004T151500
DTEND;TZID=Europe/Stockholm:20211004T161500
DTSTAMP:20260404T183112
CREATED:20210916T094629Z
LAST-MODIFIED:20210923T122426Z
UID:10000447-1633360500-1633364100@www.scilifelab.se
SUMMARY:The Svedberg seminar series: Ass. Prof. Daniel Espes
DESCRIPTION:SciLifeLab Fellow at Uppsala University \n\n\n\nLINK TO SEMINAR \n\n\n\n\n\n\n\n\n\nDaniel Espes received his completed his PhD at the Department of Medical Cell Biology\, Uppsala University\, in 2016 and became an Associate Professor (Docent) in Medical Cell Biology in 2019. In parallel with his research career he has worked actively as a clinical physician and became a specialist in internal medicine in 2019. In 2021 Espes joined as a SciLife Fellow and his translational group is focused on the development of clinically applicable techniques for assessing beta-cell mass alterations within the human pancreas during the development of diabetes. \n\n\n\nImagine Imaging Beta-Cell Mass\n\n\n\nType 1 diabetes is one of the most common chronic disease among children and adolescents. Due to the long-term complications associated with the disease the life-expectancy for those living with the disease is reduced by more than 10 years. Type 1 diabetes develops due to progressive loss of the insulin producing beta-cells following an immune attack. However\, the underlying trigger for the immune system is still unknown. At onset of hyperglycemia 60-70% of the beta-cell mass have already been lost\, based on data from autopsy studies. Currently there are no validated techniques for evaluating beta-cell mass in vivo in humans and hence our understanding of how beta-cell mass is altered in health and disease is limited to what we have learned from autopsy material. Our work is focused on establishing novel techniques for the quantification of beta-cell mass in order to increase our understanding of how diabetes develops as well as how beta-cell mass adapts in response to other conditions. In addition\, we are trying to better understand the immunological and metabolic interactions within the pancreas by combining imaging techniques with functional assessments. \n\n\n\nHost: Ass. Prof. Gustaf Christoffersson
URL:https://www.scilifelab.se/event/the-svedberg-seminar-series-assoc-prof-daniel-espes/
LOCATION:Online event via Zoom
CATEGORIES:Event
ORGANIZER;CN="The Svedberg Seminar Series":MAILTO:thesvedberg@scilifelab.uu.se
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20211005T090000
DTEND;TZID=Europe/Stockholm:20211008T170000
DTSTAMP:20260404T183112
CREATED:20210503T141305Z
LAST-MODIFIED:20210503T141929Z
UID:10000376-1633424400-1633712400@www.scilifelab.se
SUMMARY:15th Nordic Photosynthesis Congress
DESCRIPTION:You are cordially invited to attend the NPC15 at the Conference Center Wallenberg\, Gothenburg in Sweden.The congress will highlight the latest discoveries in photosynthesis and related fields along with a view to the future of how to sustain the expanding life on our planet. Alongside presentations of biological results\, there will be methodological advances\, and students and postdocs are encouraged to apply for talks. \n\n\n\nNPC15 is the only physical photosynthesis conference in Europe this year. Therefore\, we specifically welcome all international photosynthesis researchers to attend our conference. \n\n\n\nTopics\n\n\n\nMetabolic engineering of carbon fixationStructure and function of photosynthetic complexesNovel methods to study photosynthesisRegulation of photosynthesisArtificial photosynthesis and hybrid systems\n\n\n\nConfirmed invited speakers\n\n\n\nKeynote lectureEva-Mari Aro\,University of Turku\, Finland \n\n\n\nMetabolic engineering and carbon fixationCecilia Blikstad\, Uppsala University\, SwedenPeter Lindblad\, Uppsala University\, Sweden \n\n\n\nStructure and function of photosynthetic complexesMatthew Johnson\,University of Sheffield\, UKNathan Nelson\,University of Tel Aviv\, Israel \n\n\n\nNovel methods to study photosynthesisBen Engel\, Helmholtz Zentrum Munich\, GermanyAlizée Malnoë\, Umeå University\, Sweden \n\n\n\nRegulations of photosynthesisUte Armbruster\, Max Planck Institute Golm\, GermanyRoberta Croce\, University of Amsterdam\, NetherlandsBill Rutherford\, Imperial College London\, UK \n\n\n\nArtificial photosynthesis and hybrid systemsKirstin Gutekunst\,University of Kiel\, GermanyMarc Robert\, Université de Paris\, France
URL:https://www.scilifelab.se/event/15th-nordic-photosynthesis-congress/
LOCATION:Conference Centre Wallenberg\, Medicinaregatan 20A\, Gothenburg\, 413 90\, Sweden
CATEGORIES:Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20211007T110000
DTEND;TZID=Europe/Stockholm:20211007T120000
DTSTAMP:20260404T183112
CREATED:20210930T131922Z
LAST-MODIFIED:20210930T132333Z
UID:10000458-1633604400-1633608000@www.scilifelab.se
SUMMARY:The current state of modeling protein motions : from physics to AI
DESCRIPTION:Location \n\n\n\nKinnekulle\, alfa 5\, Scilifelab (limited seatings) \n\n\n\n \n\n\n\n\n\n \n\n\n\nOnline \n\n\n\njoin zoom meeting\n\n\n\n \n\n\n\n \n\n\n\n\n\nInvited speaker: \n\n\n\nSergei Grudinin\, LJK CNRS Grenoble\, France\n\n\n\nArtificial intelligence\, and more specifically deep learning\, has recently emerged as a powerful approach to exploit the massive amounts of protein sequence and structure data available nowadays toward guiding biological intervention to improve human health. A couple of months ago\, the alphaFold2 architecture from DeepMind revolutionised the field of protein structure prediction by reaching unprecedented levels of near-experimental accuracy. This achievement has been made possible mostly thanks to the latest improvements in geometric learning and natural language processing (NLP) techniques.  \n\n\n\nWhile the problem of determining how a protein folds in three dimensions (3D) is essentially solved\,  accessing protein motions is becoming more central than ever before [1]. At the European level\, the ELIXIR community is investing efforts right  now to create a comprehensive resource for structural diversity and flexibility in the Protein Data Bank (PDB)\, which contains all experimentally-determined protein 3D structures. Indeed\, proteins are flexible biological objects\, constantly moving and changing their shape to interact with their environment and cellular partners. This inherent flexibility is highly relevant for protein functioning. Experimentally\, it is very difficult to observe proteins directly in action\, and we have mostly access to isolated clusters of “snapshots” (conformations) representative of a few functional states.  \n\n\n\nI will present relatively simple physics-based models developed in our team\, where the protein is represented by an elastic network. They have proven very useful to nonlinearly extrapolate functional motions\, starting from a single structure and predict structural protein transitions [2-4]. I will also show an extension of these developments to construct a multi-level representation of protein flexibility. Then\, I will outline the current state of AI methods to model protein structural heterogeneity and connect it with the physics-based models. \n\n\n\nReferences \n\n\n\n[1] Laine\, Elodie\, et al. “Protein sequence-to-structure learning: Is this the end (-to-end revolution)?.” Proteins in Press (2021).[2] Laine\, Elodie\, and Sergei Grudinin. “HOPMA: Boosting protein functional dynamics with colored contact maps.” The Journal of Physical Chemistry B 125.10 (2021): 2577-2588.[3] Grudinin\, Sergei\, Elodie Laine\, and Alexandre Hoffmann. “Predicting protein functional motions: an old recipe with a new twist.” Biophysical journal 118.10 (2020): 2513-2525.[4] Hoffmann\, Alexandre\, and Sergei Grudinin. “NOLB: Nonlinear rigid block normal-mode analysis method.” Journal of chemical theory and computation 13.5 (2017): 2123-2134.
URL:https://www.scilifelab.se/event/the-current-state-of-modeling-protein-motions-from-physics-to-ai/
LOCATION:Online event via Zoom
CATEGORIES:Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20211011T151500
DTEND;TZID=Europe/Stockholm:20211011T163000
DTSTAMP:20260404T183112
CREATED:20210927T110517Z
LAST-MODIFIED:20211005T080643Z
UID:10000455-1633965300-1633969800@www.scilifelab.se
SUMMARY:The Svedberg seminar series: Prof.  Paolo Parini
DESCRIPTION:Theme Inflammation and Ageing\, Karolinska University Hospital\, \n\n\n\nDepartment of Laboratory Medicine and Department of Medicine \n\n\n\nKarolinska Institutet at Huddinge University Hospital\, \n\n\n\n\n\nLINK TO SEMINAR \n\n\n\n \n\n\n\n \n\n\n\n\n\n\n\n\n\nProf. Paolo Parini gained his MD degree in 1990 at the Universita’ di Bologna\, Italy. In 1994 he obtained his specialization in Gastroenterology and Hepatology (Universita’ di Bologna\, Italy). The same year Parini was registered as PhD-student at the Karolinska Institutet\, Sweden\, under the supervision of Prof Mats Rudling and Prof Bo Angelin. In 1999\, he obtained his PhD defending a thesis entitled “Hormonal regulation of hepatic cholesterol and lipoprotein metabolism: effects of estrogen and growth hormone” and since then his research activities are focused on the different aspect of lipoprotein metabolism in humans and in preclinical models. \n\n\n\nNetwork Medicine Approach to Atherosclerosis\n\n\n\nDuring the last several decades non-communicable diseases (NCDs) have dramatically increased deaths globally. One of the most prevalent NCD\, atherosclerotic cardiovascular disease (ASCVD) and cardiometabolic disease (CMD)\, are now major global health threats and socioeconomic burdens. Combined Hyperlipidemia (CH) is the most common form of hyperlipidemia and impacts longevity by promoting ASCVD\, CMD. Conventional ‘omics studies\, designed to find simple associations between genotype and phenotype in large datasets\, are inherently incapable of unraveling the complex pathobiology underlying diseases. Using network analysis\, we aim to describe the effects of the peripheral lipoprotein phenotypes of CH described in a multidimensional space by modules of functional interactions\, using patients from different existing cohorts to understand whether CH drives accelerated biological ageing\, estimated by analysis of the epigenome (DNA-methylation) in conjunction with specific ICD-10 diagnoses and treatments as a function of chronological age. We plan to integrate data of different nature [e.g.\, genetic\, epigenetic\, biochemistry\, national registries\, and electronic health record (EHR)\, and patient reported outcome measures (PROM) questionnaires]. As initial proof-of-concept\, we have created novel multi-source networks in which single-source analyses (i.e.\, liver transcriptomics and epigenomics) are integrated with biochemical parameters and lipoprotein functionality in combination with  Dr. Joseph Loscalzo´s human PPI Personal Protein I. Patients were from the Stockholm Study\, in non-obese\, normolipidemic\, gallstone patients (66% female) were randomized to a 4-week treatment with simvastatin 80 mg/day and ezetimibe 10 mg/day\, alone or in combination\, or to placebo. The first network mining has already indicated a constant and previously unknown interaction between a key gene in cholesterol metabolism and TMBIM6\, a transmembrane protein involved in autophagy and cancer information contained in the multi-source networks. Validation studies of this initial finding in going on in Soat2-only HepG2 cells\, a unique pre-clinical model which more closely resembles human lipoprotein metabolism created by us. \n\n\n\nHost: Olli Kallioniemi\, SciLifeLab Director
URL:https://www.scilifelab.se/event/the-svedberg-seminar-series-prof-paolo-parini/
LOCATION:Online event via Zoom
CATEGORIES:Event
ORGANIZER;CN="The Svedberg Seminar Series":MAILTO:thesvedberg@scilifelab.uu.se
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20211015T090000
DTEND;TZID=Europe/Stockholm:20211015T093000
DTSTAMP:20260404T183112
CREATED:20210921T171433Z
LAST-MODIFIED:20211014T114429Z
UID:10000450-1634288400-1634290200@www.scilifelab.se
SUMMARY:Clinical Talks: Playing your way to healthy life
DESCRIPTION:On October 15\, it’s our great pleasure to host Professor Emma Lundberg once again. This time she will focus her Talk on her innovative company Mindforce GameLab. With the Fig platform\, patients can via gamification transform into “playtients”\, people with medical conditions who enjoy playing games with a purpose to establish healthy habits. Fig guides you on the journey to better health\, including improved behavioral administration of medicals for intended and sustainable use. \n\n\n\nEmma Lundberg SciLifeLab. \nFoto © Daniel Roos\n\n\n\nEmma is a Professor in cell biology proteomics at KTH Royal Institute of Technology\, Sweden\, and Director of the Cell Atlas\, part of the Human Protein Atlas program. She spent two and half sabbatical years as visiting Associate Professor at Stanford School of Medicine and the Chan-Zuckerberg Biohub. In the interface between bioimaging\, proteomics and artificial intelligence her research aims to define the spatiotemporal organization of the human proteome at a subcellular level\, with the goal to understand how variations and deviations in protein expression patterns can contribute to cellular function and disease.  \n\n\n\nShe also has a keen interest\, passion\, and fascination in the use of gaming for science and health applications. This led Emma to start her own company in 2017\, Skellefteå based Mindforce Game Lab\, with the goal to unleash the powerful potential gamification could offer medical healthcare. Simply phrased\, medicines will not work if people do not take them. Despite this\, only every other person takes their medication as prescribed. This is a fundamental challenge for treating many chronic diseases\, in terms of patient outcomes\, as well as the overall burden on healthcare systems. Although there are products that help patients with extrinsic motivations\, such as reminders and notifications\, Mindforce Game Lab focuses on intrinsic motivations; designing games that build in feelings of companionship\, belonging and purpose. Patients learn how healthy routines\, such as sleeping well\, eating well\, exercising regularly\, and adhering to prescribed medication\, can improve feelings of well-being. This builds an inner driving force to want to change behaviour and to maintain a healthy lifestyle. In late 2020 Mindforce Game Lab joined the AstraZeneca BioVentureHub and relocated the development team to Gothenburg. \n\n\n\nRegister to receive zoom link\n\n\n\n\n\n\n\nAfter our recent planning hiatus\, we now have the great pleasure to announce that “Clinical Talks” has been renewed for yet another exciting\, innovative\, and enlightening season. This season will focus on sustainable innovations within Life Sciences\, that have the potential to contribute to a better climate friendly future for our future generations. Also new this year is that the seminar is co-organized in a collaboration between SciLifeLab and KI Innovations. \n\n\n\nRead more
URL:https://www.scilifelab.se/event/playing-your-way-to-healthy-life/
LOCATION:Online event via Zoom
CATEGORIES:Event
ATTACH;FMTTYPE=image/jpeg:https://www.scilifelab.se/wp-content/uploads/2021/09/ClinicalTalks_Emma-Lundberg_1024-1.jpg
ORGANIZER;CN="Clinical Talks":MAILTO:precisionmedicine@scilifelab.se
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20211015T093000
DTEND;TZID=Europe/Stockholm:20211015T113000
DTSTAMP:20260404T183112
CREATED:20210922T144136Z
LAST-MODIFIED:20210922T173935Z
UID:10000451-1634290200-1634297400@www.scilifelab.se
SUMMARY:Virtual coffee drop in session - COVID-19 Data &  Code Reuse Competition 
DESCRIPTION:Location: Online via Zoom\n\n\n\nThe Swedish COVID-19 Data Portal invites you to join us for a Virtual coffee drop-in session and discussion about COVID-19 Data & Code Reuse Competition submissions. Take this opportunity to get support and ask questions about your ideas\, planned or  already started project for the competition. Drop-in for a chat with us and other participants\, we look forward to meet you. \n\n\n\nAbout the COVID-19 Data & Code Reuse Competition \n\n\n\nThe Swedish COVID-19 Data Portal invites researchers and general public to take part in the COVID-19 Data & Code Reuse Competition. Participants should complete small-scale projects that make use of publicly shared data and/or code to combat the COVID-19 pandemic or any future pandemics. \n\n\n\nWe welcome various types of project. The projects could\, for example\, involve the re-analysis of existing publicly available data using a different method\, or focus on a different aim\, or reuse publicly shared code to process a new set of data. Other possibilities include projects that produce individual visualizations\, dashboards presenting publicly shared data in a novel way or web-services devoted to data and analysis. The emphasis of the projects submitted should be to maximize the utility of existing data and/or code. \n\n\n\n\n\n\n\nRegister before October 14 to receive the Zoom link and allow planning of resources \n\n\n\nContact: SciLifeLab Data Centre\, datacentre@scilifelab.se \n\n\n\nRegister here
URL:https://www.scilifelab.se/event/virtual-coffee-drop-in-session-covid-19-data-code-reuse-competition/
LOCATION:Online event via Zoom
CATEGORIES:Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20211018T151500
DTEND;TZID=Europe/Stockholm:20211018T161500
DTSTAMP:20260404T183112
CREATED:20210916T151516Z
LAST-MODIFIED:20210927T100311Z
UID:10000448-1634570100-1634573700@www.scilifelab.se
SUMMARY:The Svedberg seminar series: Ass. Prof. Prashant Singh
DESCRIPTION:SciLifeLab Fellow at Uppsala University \n\n\n\nLINK TO SEMINAR \n\n\n\n\n\n\n\n\n\nPrashant Singh is a SciLifeLab fellow and Assistant Professor hosted by the Division of Scientific Computing\, Department of Information Technology\, Uppsala University. His research interests involve developing machine learning and optimization methods to enable fast\, data-efficient analysis and processing of scientific data\, particularly in the domain of life sciences. \n\n\n\nScalable Likelihood-Free Parameter Inference of Stochastic Biochemical Reaction Networks\n\n\n\nAbstract: Parameter inference of stochastic time series models\, such as gene regulatory networks in the likelihood-free setting is a challenging task\, particularly when the number of parameters to be inferred is large. Recently\, data-driven machine learning models (neural networks in particular) have delivered encouraging results towards addressing the scalability\, efficiency and parameter inference quality of the likelihood-free parameter inference pipeline. In particular\, this talk will present a detailed discussion on neural networks as trainable\, expressive and scalable summary statistics of high-dimensional time series for parameter inference tasks. \n\n\n\nReference: \n\n\n\nM. Akesson\, P. Singh\, F. Wrede and A. Hellander\, “Convolutional Neural Networks as Summary Statistics for Approximate Bayesian Computation\,” in IEEE/ACM Transactions on Computational Biology and Bioinformatics\, doi: 10.1109/TCBB.2021.3108695. \n\n\n\nHost: Prof. Elisabeth Larsson\, Uppsala University
URL:https://www.scilifelab.se/event/the-svedberg-seminar-series-assoc-prof-prashant-singh/
LOCATION:Online event via Zoom
CATEGORIES:Event
ORGANIZER;CN="The Svedberg Seminar Series":MAILTO:thesvedberg@scilifelab.uu.se
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20211019T143000
DTEND;TZID=Europe/Stockholm:20211022T183000
DTSTAMP:20260404T183112
CREATED:20210524T143123Z
LAST-MODIFIED:20211007T121821Z
UID:10000392-1634653800-1634927400@www.scilifelab.se
SUMMARY:International Advisory Board meeting 2021
DESCRIPTION:The site visit has become a digital Zoom meeting. We welcome the International Advisory Board (IAB) of SciLifeLab to a 4-day meeting on October 19-22\, 2021. During the meeting\, we will discuss and seek guidance about SciLifeLab and its future plans. A background report\, prepared by the SciLifeLab management\, is sent to the IAB members. \n\n\n\n \n\n\n\n\nIAB Program\n\n\n\n\n\n\n\n\n\n\n\n\nPicture taken during the IAB visit in 2019. Left to right\, back to front row: Svante Pääbo\, Jonathan Knowles\, Yoshihide Hayashizaki\, Jo Bury\, Carl-Henrik Heldin\, Jan Ellenberg\, Annika Jenmalm Jensen\, Olli Kallioniemi\, Sarah Teichmann\, Sirpa Jalkanen\, Janet Jansson and Sören Brunak.
URL:https://www.scilifelab.se/event/international-advisory-board-meeting-2021/
CATEGORIES:Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20211021T143000
DTEND;TZID=Europe/Stockholm:20211021T151500
DTSTAMP:20260404T183112
CREATED:20211005T093455Z
LAST-MODIFIED:20211005T093615Z
UID:10000461-1634826600-1634829300@www.scilifelab.se
SUMMARY:[Big Talks] – Transposon Genomics — From Single Loci To Single Cells
DESCRIPTION:Invited speaker \n\n\n\nMolly Gale Hammell\, Associate Professor\, Cold Spring Harbor Laboratory\, USA \n\n\n\n \n\n\n\nAbstract\n\n\n\nTransposable Elements (TEs) are sequences in the human genome that have (or once had) the ability to mobilize from one location in the genome to another. Most of the TEs that currently exist in the human genome are fixed and unable to mobilize\, but many of these sequences have some residual level of functionality. These residual functions might include: the ability to bind DNA- or RNA-binding factors and act as regulatory elements\, the ability to generate RNA transcripts\, and/or the ability to encode proteins. Because TEs are extremely abundant in the human genome\, covering nearly 45% of the sequence space\, active TEs can have a large\, and often deleterious\, impact on host cell function. Multiple studies have shown aberrant elevation of TE expression in aging-associated diseases\, such as neurodegeneration and cancer. However\, establishing a causal role for TE activity in these contexts requires tracking down the individual TE loci that are active\, and distinguishing these from the thousands of other TE loci that are silent and/or non-functional. This is still an unsolved problem in the field of transposon genomics\, but new tools and technologies are making the problem more tractable. These include long-read technologies\, and improved statistical methods for analyzing TE expression and integrating TE multi-omics datasets. Once aberrantly active TE loci are identified\, it’s often important to know which cell type is harboring these activated TEs\, and whether certain cells are more vulnerable to TE activity than others. Integrating TE expression analysis into single-cell genomics workflows is crucial to understanding how these elements contribute to human disease. I will present recent results from my lab that tackle these issues in the context of neurodegeneration\, where elevated transposons are thought to contribute to neurotoxicity\, and may also contribute to neuroinflammation.  \n\n\n\nBiography\n\n\n\n\n\n\n\nThe Gale Hammell lab uses a combination of computational and experimental methods to understand how gene regulatory networks are perturbed in human disease. This includes an emphasis on developing novel tools for the statistical analysis of high-throughput data\, developing novel algorithms for modeling the flow of signals through genetic pathways\, and importantly\, testing these models using the tools of molecular genetics. One particular focus of the M. Hammell lab is to apply these novel statistical analysis methods to better understand how transposable elements are normally controlled. Mounting evidence has implicated transposon activity in a host of human diseases\, with particular evidence for activation in several neurodegenerative diseases\, including Amyotrophic lateral sclerosis (ALS)\, Fronto-Temporal Dementia (FTD)\, and Alzheimer’s Disease (AD). By combining the power of systems-level\, high-throughput data analysis with patient-derived ALS\, FTD\, and AD tissue samples\, the lab aims to better understand how these viral-like sequences contribute to cell death and disease. \n\n\n\n\n\n\n\nHost: Louella Vasquez\, NBIS Lund (louella.vasquez@scilifelab.se) \n\n\n\nDate: October 21\, 14:30 – 15:15 CET online on YouTube \n\n\n\nBroadcast link (live event): SBW YouTube channelThe talk will also be available afterwards on the SciLifeLab YouTube channel.More information about the Swedish Bioinformatics Workshop here.
URL:https://www.scilifelab.se/event/big-talks-transposon-genomics-from-single-loci-to-single-cells/
CATEGORIES:Event
ORGANIZER;CN="Swedish Bioinformatics Workshop":MAILTO:louella.vasquez@scilifelab.se
LOCATION:https://www.scilifelab.se/event/big-talks-transposon-genomics-from-single-loci-to-single-cells/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20211021T170000
DTEND;TZID=Europe/Stockholm:20211021T173000
DTSTAMP:20260404T183112
CREATED:20210928T135950Z
LAST-MODIFIED:20211005T094033Z
UID:10000457-1634835600-1634837400@www.scilifelab.se
SUMMARY:Clinical Talks: Writing the Future
DESCRIPTION:Writing the Future\n\n\n\nOn October 21\, Dr. Emily Leproust will talk about her mission with co-founding Twist Bioscience\, and how their revolutionary oligosynthesis plattform is writing the future with DNA.  \n\n\n\nTwist Bioscience’s innovative silicon-based DNA Synthesis Platform is empowering our customers to realise their research goals faster. Twist offers DNA synthesis at an unmatched scale and price point\, without compromising on precision or quality. Here we discuss how DNA synthesis at scale can make traditional molecular biology approaches redundant in labs working with plasmid vectors; can power massive\, explicit diversity in CRISPR and antibody variant libraries; and can underpin NGS Target Enrichment Solutions with exceptional performance and unmatched speed in customisation. We’ll look at how these tools are helping drive innovation in a variety of research and application areas including cancer research\, drug discovery\, infectious disease and even data storage. \n\n\n\nAs an early pioneer in the high-throughput synthesis and sequencing of DNA\, Dr. Leproust is disrupting markets to enable the exponential growth of DNA-based applications including chemicals/materials\, diagnostics\, therapeutics\, food and digital data storage. In 2020\, BIO presented her with the Rosalind Franklin Award for Leadership. Foreign Policy named her one of their 100 Leading Global Thinkers and Fast Company named her one of the Most Creative People in Business. Prior to Twist Bioscience\, she held escalating positions at Agilent Technologies where she architected the successful SureSelect product line that lowered the cost of sequencing and elucidated mechanisms responsible for dozens of Mendelian diseases. She also developed the Oligo Library Synthesis technology\, where she initiated and led product and business development activities for the team. Dr. Leproust designed and developed multiple commercial synthesis platforms to streamline microarray manufacturing and fabrication. She serves on the Board of Directors of CM Life Sciences and is a co-founder of Petri\, an accelerator for start-ups at the forefront of engineering and biology. Dr. Leproust has published over 30 peer-reviewed papers – many on applications of synthetic DNA\, and is the author of numerous patents. She earned her Ph.D. in Organic Chemistry from University of Houston and her M.Sc. in Industrial Chemistry from the Lyon School of Industrial Chemistry. \n\n\n\nregistration\n\n\n\n\n\n\n\nSeason 5\, will be held September until December 2021 with scheduled Talks\, during Friday mornings 09-09:30 am via ZOOM (with some time-zone friendly adjustments for our international speakers). Each session consists of a talk given by our invited speaker followed by Q&A. The seminar is an open educational seminar series for our ever-expanding Life Science community. \n\n\n\nAfter our recent planning hiatus\, we now have the great pleasure to announce that “Clinical Talks” has been renewed for yet another exciting\, innovative\, and enlightening season. This season will focus on sustainable innovations within Life Sciences\, that have the potential to contribute to a better climate friendly future for our future generations. Also new this year is that the seminar is co-organized in a collaboration between SciLifeLab and KI Innovations. \n\n\n\nRead more
URL:https://www.scilifelab.se/event/clinical-talks-writing-the-future/
LOCATION:Online event via Zoom
CATEGORIES:Event
ATTACH;FMTTYPE=image/jpeg:https://www.scilifelab.se/wp-content/uploads/2021/09/ClinicalTalks_Season5_twitter_1024.jpg
ORGANIZER;CN="Clinical Talks":MAILTO:precisionmedicine@scilifelab.se
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20211026T130000
DTEND;TZID=Europe/Stockholm:20211026T160000
DTSTAMP:20260404T183112
CREATED:20210928T124945Z
LAST-MODIFIED:20211018T141735Z
UID:10000456-1635253200-1635264000@www.scilifelab.se
SUMMARY:DNP inauguration ceremony
DESCRIPTION:We are very happy to announce the unique collaboration between AstraZeneca and University of Gothenburg on advanced NMR technology\, manifested in the inauguration ceremony of our new DNP-NMR instrument! \n\n\n\nWelcome to the DNP inauguration ceremony to celebrate the DNP-NMR instrument investment at the Swedish NMR Centre\, University of Gothenburg! \n\n\n\nThe ceremony will take place between 13.00 – 16.00 on October 26 in lecture hall Birgit Thilander\, Medicinaregatan 3\, Gothenburg. \n\n\n\nInvited guest speaker professor Lyndon Emsley from EPFL Lausanne will close the ceremony by giving a lecture between 15.00 – 16.00. \n\n\n\nPlease respond before October 16. \n\n\n\nregistration\n\n\n\nProgram\n\n\n\n13.00Welcome remarksWelcome – Göran Karlsson\, Director Swedish NMR Centre\, and Staffan Schantz\, APS AstraZenecaGothenburg ecosystem view – Matti Ahlqvist\, AstraZeneca Gothenburg Executive Site DirectorPharmaceutical development – Piet van den Oetelaar\, Head OPD/AstraZenecaUniversity Research Infrastructures – Göran Hilmersson\, Dean\, The Faculty of Science\, University of Gothenburg.13.45Tour to the new DNP-NMR instrumentArthur Pinon\, SNC14.30Light snacks & refreshments15.00Structure Activity Relations in Materials from DNP-NMRLyndon Emsley\, EPFL Lausanne16.00Closing\n\n\n\n \n\n\n\nOn behalf of the inauguration ceremony team\, \n\n\n\nStaffan Schantz\, AstraZeneca\, Göran Karlsson\, University of Gothenburg\, Ulrika Brath\, University of Gothenburg Nina Berg\, AstraZeneca 
URL:https://www.scilifelab.se/event/dnp-inauguration-ceremony/
LOCATION:Birgit Thilander Lecture Hall\, Medicinaregatan 3\, Göteborg
CATEGORIES:Event
ATTACH;FMTTYPE=image/jpeg:https://www.scilifelab.se/wp-content/uploads/2021/09/image001.jpg
ORGANIZER;CN="Swedish NMR Centre":MAILTO:info@nmr.gu.se
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20211027T080000
DTEND;TZID=Europe/Stockholm:20211029T170000
DTSTAMP:20260404T183112
CREATED:20210906T122129Z
LAST-MODIFIED:20210906T122916Z
UID:10000439-1635321600-1635526800@www.scilifelab.se
SUMMARY:nf-core hackathon
DESCRIPTION:Mark your calendars to join us for the October 2021 nf-core hackathon! \n\n\n\nWith the recent release of the new nf-core template for Nextflow’s DSL2\, in this event we will be going full-steam ahead with conversion of nf-core pipelines from DSL1 to DSL2. The main objectives of this hackathon will be adding nf-core modules and rewriting existing pipelines to the new Nextflow language format. \n\n\n\nFor Nextflow novices\, we will be looking for help in writing Nextflow modules of commonly used bioinformatics tools. \n\n\n\nFor more experienced developers we hope for contributions to writing subworkflows and pipeline code. \n\n\n\nIn the spirit of collaboration and knowledge sharing\, we plan to pair up both novices and experienced developers in pair programming to help get newcomers up to speed on writing and contributing nf-core modules through a pair-programming session for a limited number of participants. Make sure to sign up by September 27\, 2021 to participate in pair-programming! \n\n\n\nThis event is entirely virtual and we are attempting to support people in all timezones. Do get in touch with us if you’d like to help us out! \n\n\n\nRead more and sign up
URL:https://www.scilifelab.se/event/nf-core-hackathon/
CATEGORIES:Event
ATTACH;FMTTYPE=image/png:https://www.scilifelab.se/wp-content/uploads/2021/09/nf-core-logo.png
LOCATION:https://www.scilifelab.se/event/nf-core-hackathon/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20211027T151500
DTEND;TZID=Europe/Stockholm:20211027T164500
DTSTAMP:20260404T183112
CREATED:20211011T121542Z
LAST-MODIFIED:20211012T094117Z
UID:10000462-1635347700-1635353100@www.scilifelab.se
SUMMARY:SciLifeLab COVID-19 seminars: Aaron Bivins and Anna Székely
DESCRIPTION:The third seminar in this series starts with Aaron Bivins\, Post-Doctoral Research Associate\, Department of Civil & Environmental Engineering & Earth Sciences\, University of Notre Dame\, who will talk about Wastewater surveillance for COVID-19 in a vaccinated world.  \n\n\n\nAnna Székely\, Associate Professor\, Researcher at the Department of Aquatic Sciences and Assessment; Section for Ecology and Biodiversity\, Swedish University of Agricultural Sciences (SLU)\, then continues the seminar by talking about Experiences and challenges of Swedish wastewater measurements: from research project to national monitoring \n\n\n\nHost:  Zeynep Cetecioglu Gurol\, KTH \n\n\n\n\n\n\n\nRegistration is mandatory to get the Zoom link for the event \n\n\n\n\n\n\n\n\n\n\n\n\nREGISTRATION\n\n\n\n\n\n\n\n\n\nBIOS and ABSTRACTS\n\n\n\n\n\n\n\n\n\n\n\n\nProgram\n\n\n\n15:15Wastewater surveillance for COVID-19 in a vaccinated world Aaron Bivins\, Post-Doctoral Research Associate\, University of Notre Dame  16:00Experiences and challenges of Swedish wastewater measurements: from research project to national monitoring Anna Székely\, Associate Professor\, Researcher\, SLU
URL:https://www.scilifelab.se/event/scilifelab-covid-19-seminars-aaron-bivins-and-anna-szekely/
LOCATION:Online event via Zoom
CATEGORIES:Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20211028T130000
DTEND;TZID=Europe/Stockholm:20211028T140000
DTSTAMP:20260404T183112
CREATED:20210930T150158Z
LAST-MODIFIED:20211014T151926Z
UID:10000459-1635426000-1635429600@www.scilifelab.se
SUMMARY:[Drug Discovery Seminars] Targeting the oncogenic TGFβ signaling pathway in cancer to inhibit invasion and metastasis
DESCRIPTION:Maréne Landström \n\n\n\nOctober 28\, 13:00-14:00 \n\n\n\n \n\n\n\nregistration\n\n\n\nWelcome to join this Drug Discovery Seminar hosted by the Drug Discovery and Development Platform. \n\n\n\nPresenter: \n\n\n\nProfessor Maréne Landström\, M.D.\, PhD \n\n\n\nDept. Medical Biosciences\, Umeå University \n\n\n\nMaréne Landström is a professor in Pathology at Department of Medical Biosciences\, Umeå University\, Sweden. She has made her postdoctoral training at the Ludwig Institute of Cancer Research\, Uppsala Branch and have also been a group leader at Department of Immunology\, Genetics and Pathology\, Uppsala University before taking on her current position. \n\n\n\nAbstract: \n\n\n\nTransforming growth factor beta (TGFb) is frequently overexpressed in several forms of cancer including prostate cancer and this has been shown to correlate with poor prognosis. TGFb is transducing its canonical and non-canonical signals via its transmembrane TGFb Type II and Type I receptors (TbRII/TbRI) which are serine-threonine kinases. We have found that the TbRI undergoes proteolytic cleavage in cancer cells in a manner dependent on the ubiquitin-ligase tumor necrosis factor (TNF) receptor-associated factor 6 (TRAF6). The intracellular domain of TbRI (TbRI-ICD) is released from the cell membrane\, soluble and is transported to the nucleus in some specific forms of cancer to promote expression of genes causing invasion and metastatic growth. In collaboration with SciLifeLab DDD we have generated potential therapeutic antibodies to target this pathway which we are investigating the function of\, in our established preclinical models for prostate cancer.
URL:https://www.scilifelab.se/event/drug-discovery-seminars-targeting-the-oncogenic-tgf%ce%b2-signaling-pathway-in-cancer-to-inhibit-invasion-and-metastasis/
LOCATION:Online event via Zoom
CATEGORIES:Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20211029T090000
DTEND;TZID=Europe/Stockholm:20211029T093000
DTSTAMP:20260404T183112
CREATED:20211014T115257Z
LAST-MODIFIED:20211028T115510Z
UID:10000464-1635498000-1635499800@www.scilifelab.se
SUMMARY:Clinical Talks: Blood-based methods for predicting the day of labor
DESCRIPTION:On October 29\, we will host a dual presentation with Dr. Ina Stelzer and Associate Professor Brice Gaudillière. At the Stanford School of Medicine Clinical Gaudillière laboratory\, Ina and Brice have developed a groundbreaking multi-omics approach to track the maternal metabolome\, proteome and immunome to predict exact labor onset. Estimating the time of delivery is of high clinical importance to minimize pre- and post-term deviations causing complications and suffering with ultimately more streamlined use of medical resources for a sustainable future. \n\n\n\n \n\n\n\nRead more about clinical talks\n\n\n\n\n\n\n\nIna is a molecular biologist and immunologist with an extensive background in pregnancy immunology. She obtained her PhD in Immunology 2017 from the University Medical Center Hamburg-Eppendorf (part of the University of Hamburg). Her work then focused on the immunology of pregnancy and feto-maternal immune crosstalk with a focus on fetal origin of disease development later in life. Ina is currently pursuing her postdoctoral research at Stanford University in the Gaudillière laboratory. Building on her expertise in preclinical (mouse) models of pregnancy and translational systems immunology\, her research leverages state-of-the-art single cell proteomic techniques (suspension and imaging mass cytometry) to study feto-maternal immune adaptations in healthy and pathological pregnancies with the goal to improving the health of mothers and their children. Her current K99/R00-funded work investigates the neuro-immune axis in normal pregnancy and the pathogenesis of pregnancy complications. While at Stanford during 2021\, Ina also recently completed the prestigious Stanford University Graduate School of Business organized Stanford Ignite certificate program. \n\n\n\n\n\n\n\nAssociate Professor Brice Gaudillière initially studied Engineering at Ecole Polytechnique in Paris before completing an MD-PhD degree from the Harvard-MIT Health Sciences and Technology program in 2009. During his postdoctoral fellowship at Stanford University in Dr. Garry Nolan’s laboratory\, he developed and standardized a pipeline to implement CyTOF in clinical studies. Brice is also a Board Certified Anesthesiologist and works clinically in the operating room 25% of his time. \n\n\n\nGaudilliere’s research group combines high parameter mass cytometry (suspension and imaging mass cytometry) with other proteomics approaches to study how the human immune system responds and adapts to physiological or pathological stressors. Ongoing studies in the Gaudilliere lab focus on several clinical scenarios including\, 1) surgical recovery and traumatic injury (NIGMS R35\, Stanford ITI\, Anesthesia department FIDL\, 2) pregnancy and preterm birth (Doris Duke Foundation\, Stanford Prematurity Center grants from the Bill and Melinda Gates and the March of Dimes Foundation\, 3) Host immune response to COVID-19 infection (FAST grant)\, 4) neurocognitive recovery after stroke (PHIND grant). \n\n\n\nregister here
URL:https://www.scilifelab.se/event/blood-based-methods-for-predicting-the-day-of-labor/
LOCATION:Online event via Zoom
CATEGORIES:Event
ATTACH;FMTTYPE=image/jpeg:https://www.scilifelab.se/wp-content/uploads/2021/09/ClinicalTalks_Season5_twitter_1024.jpg
ORGANIZER;CN="Clinical Talks":MAILTO:precisionmedicine@scilifelab.se
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20211102T090000
DTEND;TZID=Europe/Stockholm:20211102T100000
DTSTAMP:20260404T183112
CREATED:20210902T060701Z
LAST-MODIFIED:20211019T152930Z
UID:10000425-1635843600-1635847200@www.scilifelab.se
SUMMARY:BioImage Informatics Call4Help Webinar: CellPose
DESCRIPTION:For our next Call4Help session we are organizing a tool-presentation seminar about CellPose\, a generalist algorithm for cell and nuclei segmentation. CellPose is a deep learning-based segmentation method trained on a wide range of image types. It can be applied to both 2D and 3D images.  \n\n\n\nDuring this seminar we will explore different ways to run CellPose\, including demos powered by the ImJoy server which aim to make it easier for users to analyse large datasets in computing clusters. The webinar will be given by Gisele Miranda (BIIF) and Wei Ouyang (KTH\, developer of ImJoy) and will take place on November 2nd\, 09:00-10:00. There will be time for questions and discussion\, so we hope this event to be very interactive. Please register here. \n\n\n\nregistration\n\n\n\nImportant links\n\n\n\nhttps://github.com/MouseLand/cellposehttps://imjoy.io/
URL:https://www.scilifelab.se/event/bioimage-informatics-call4help-5/
CATEGORIES:Event
ORGANIZER;CN="Bioimage Informatics Unit":MAILTO:biif@scilifelab.se
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20211103T151500
DTEND;TZID=Europe/Stockholm:20211103T164500
DTSTAMP:20260404T183112
CREATED:20211021T083636Z
LAST-MODIFIED:20211027T132303Z
UID:10000472-1635952500-1635957900@www.scilifelab.se
SUMMARY:SciLifeLab COVID-19 seminars: Lars Juhl Jensen and Sonja Aits
DESCRIPTION:The fourth seminar in this series starts with Lars Juhl Jensen\, Professor\, Novo Nordisk Foundation Center for Protein Research\, Faculty of Health and Medical Sciences\, University of Copenhagen\, who will talk about From intraspecies protein networks to host–pathogen networks.  \n\n\n\nSonja Aits\, Associate senior lecturer at Cell Death\, Lysosomes and Artificial Intelligence\, Lund University\, then continues the seminar with a talk on Text mining for COVID-19 knowledge extraction \n\n\n\n\n\n\n\n Registration is mandatory to get the Zoom link for the event  \n\n\n\n\nREGISTRATION\n\n\n\nBIOS & ABSTRACTS
URL:https://www.scilifelab.se/event/scilifelab-covid-19-seminars-lars-juhl-jensen-and-sonja-aits/
LOCATION:Online event via Zoom
CATEGORIES:Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20211108T093000
DTEND;TZID=Europe/Stockholm:20211108T103000
DTSTAMP:20260404T183112
CREATED:20210609T090521Z
LAST-MODIFIED:20210826T100254Z
UID:10000400-1636363800-1636367400@www.scilifelab.se
SUMMARY:Career path discussions with Jennifer Lippincott-Schwartz
DESCRIPTION:Jennifer Lippincott-Schwartz from the Howard Hughes Medical Institute will give an account of her career path and discuss with students and postdocs at 09.30 in the SciLifeLab Air&Fire auditorium. Since the number of places is limited\, please register below to participate in this session. \n\n\n\n\n\n\n\nRegister\n\n\n\n\n\n\n\nUsing cutting-edge\, superresolution imaging technology to visualize cellular activity at the nano-scale\, Lippincott-Schwartz lab has redefined how we look at protein dynamics in the cell. When describing her mentorship philosophy\, Jennifer comments that she encourages her group members to develop their own projects. It is only when a colleague feels that he or she “owns” the project that real dedication\, determination\, and creativity emerge. In developing projects\, she considers it is important to build on the strengths and interests of students and postdocs\, rather than focusing exclusively on a group leader’s specific interests at the time. \n\n\n\nThe annual lecture series is set up in the recognition of the development of electron microscopy and will be delivered by eminent scientists in the field of structural biology and molecular visualisation. The event is open to anyone. The main lecture will take place at 4.00pm in the Biomedicum Lecture Theatre. \n\n\n\nContact \n\n\n\nAlexey Amunts\, amunts@scilifelab.se
URL:https://www.scilifelab.se/event/career-path-discussions-with-jennifer-lippincott-schwartz/
LOCATION:Air&Fire\, SciLifeLab Stockholm\, Tomtebodavägen 23A\, Solna\, Sweden
CATEGORIES:Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20211108T151500
DTEND;TZID=Europe/Stockholm:20211108T163000
DTSTAMP:20260404T183112
CREATED:20211005T080424Z
LAST-MODIFIED:20211005T080541Z
UID:10000460-1636384500-1636389000@www.scilifelab.se
SUMMARY:The Svedberg seminar series: Ass. Prof. Maria Kasper
DESCRIPTION:Karolinska Institutet\, Department of Cell and Molecular Biology\, Sweden \n\n\n\nLINK TO SEMINAR   \n\n\n\n\n\n\n\n\n\nMaria Kasper is Associate Professor at the Karolinska Institutet in Stockholm\, Department of Cell and Molecular Biology. She received her PhD at the University of Salzburg in genetics\, with the majors in human genetics and molecular tumor biology. She came to Sweden in 2007\, where she spent a fruitful postdoctoral time in Rune Toftgårds lab\, and in 2013 she started her own lab focusing on skin\, stem cell biology and single-cell RNA sequencing. In 2016\, her lab pioneered the use of single-cell transcriptomics in the organ skin and has overall contributed with important work in skin biology and regenerative medicine. Maria has received a number of national recognitions such as the Framtidens Forskningsledare from SSF\, Ragnar Söderberg Fellow in Medicine and the CIMED young investigator award\, as well as the prestigious international LEO Foundation Gold Award for outstanding skin research. Since 2020\, she also coordinates together with Fiona Watt the Human Cell Atlas bionetwork for the organ skin. \n\n\n\nDecoding the molecular anatomy of skin\n\n\n\nSkin architecture and its function are determined by a rich variety of epithelial\, mesenchymal and immune cells that together orchestrate skin homeostasis\, including cyclical hair growth and barrier function. Previously\, my lab generated a comprehensive molecular and spatial atlas of epithelial and stromal cells during hair growth and rest. These studies revealed underlying molecular programs during progenitor-cell commitment and lineage differentiation\, as well as spatiotemporal fibroblast heterogeneity and potential epithelial-stromal interactions. The importance of cell-type specific signaling during homeostasis\, and the unrecognized potential of cell-type restricted signaling-changes were exemplified by our recent discovery of how to induce new hair follicles in adult mouse skin by modulating a single signaling pathway. Building on the molecular knowledge and computational skills gained\, our ongoing work uncovers new insights in the molecular orchestration of embryonic hair follicle development\, as well as the coordination of adult skin stem cell differentiation by tissue resident immune cells.Host: Gabriella Lindgren\, SLU
URL:https://www.scilifelab.se/event/the-svedberg-seminar-series-ass-prof-maria-kasper/
LOCATION:Online event via Zoom
CATEGORIES:Event
ORGANIZER;CN="The Svedberg Seminar Series":MAILTO:thesvedberg@scilifelab.uu.se
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20211108T160000
DTEND;TZID=Europe/Stockholm:20211108T170000
DTSTAMP:20260404T183112
CREATED:20210609T090256Z
LAST-MODIFIED:20210826T100440Z
UID:10000399-1636387200-1636390800@www.scilifelab.se
SUMMARY:Annual lecture in structural biology by Jennifer Lippincott-Schwartz
DESCRIPTION:Jennifer Lippincott-Schwartz from the Howard Hughes Medical Institute will give the lecture entitled ‘Emerging Imaging Technologies to Study Cell Architecture\, Dynamics\, and Function’ on November 8\, 2021 at 4.00pm in the Biomedicum lecture theatre. Using cutting-edge\, superresolution imaging technology to visualize cellular activity at the nano-scale\, Lippincott-Schwartz lab has redefined how we look at protein dynamics in the cell. \n\n\n\nThe annual lecture series is set up in the recognition of the development of electron microscopy and will be delivered by eminent scientists in the field of structural biology and molecular visualisation. The event is open to anyone. A holder of the lectureship will particularly spend time with students and postdocs. Therefore\, Jennifer will also give an account of her career path and discuss with students and postdocs at 09.30am in the SciLifeLab Air&Fire auditorium. \n\n\n\nAbout Jennifer Lippincott-Schwartz \n\n\n\nResearch in Lippincott-Schwartz lab is aimed at developing live cell imaging to elucidate the dynamics inside eukaryotic cells. She pioneered photobleaching and photoactivation techniques which allow investigation of subcellular localization\, turnover and trafficking of important cellular proteins related to membrane compartmentalization. Her work on photoactivatable GFP led to the development of one of the first super-resolution imaging technologies\, photoactivation localization microscopy. Jennifer then used her methods to assess organelles dynamics and interactions revealing a novel picture of how the peripheral endoplasmic reticulum is structured. In addition\, the Golgi apparatus is central to Jennifer’s studies\, where her team demonstrated a novel pathway of enzymes recycling important for the organelle’s biogenesis and maintenance. Together\, the obtained findings have provided insights into how genetic diseases affect proteins that help shape the endoplasmic reticulum. \n\n\n\nIn 2016\, Lippincott-Schwartz initiated the Neuronal Cell Biology Program at Janelia. She is Fellow of the American Academy of Arts and Sciences Fellow\, and also Honorary Fellow of the Royal Microscopical Society.  \n\n\n\nBackground information \n\n\n\nThe annual lecture in structural biology is named in honour of Fritiof Sjöstrand\, who pioneered the electron microscopy in Sweden. In the early 1950’s he developed an advanced microtome for thin sectioning\, and by applying it for structural analysis of mitochondria produced a major breakthrough with the determination of the double membrane system. He then engineered a next generation of microtomes using electrical heating of the specimen to advance it toward the knife\, and the instrument became known as the ‘‘Sjöstrand Ultramicrotome”. In 1959\, Fritiof Sjöstrand moved to UCLA\, where his research focused on mitochondrial membranes and retinal synapses. Fritiof Sjöstrand founded and was Editor in Chief of the Journal of Structural Biology for 33 years. Lectures in the previous years were given by Venki Ramakrishnan and Jennifer Doudna. \n\n\n\nContact \n\n\n\nAlexey Amunts\, amunts@scilifelab.se
URL:https://www.scilifelab.se/event/emerging-imaging-technologies-to-study-cell-architecture-dynamics-and-function/
LOCATION:Biomedicum\, Solnavägen 9\, Solna
CATEGORIES:Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20211109T100000
DTEND;TZID=Europe/Stockholm:20211109T110000
DTSTAMP:20260404T183112
CREATED:20211102T153126Z
LAST-MODIFIED:20211102T153315Z
UID:10000478-1636452000-1636455600@www.scilifelab.se
SUMMARY:The curious case of a leak channel that never wants to be open
DESCRIPTION:Stephan Pless\, PhD \n\n\n\nProfessor of Molecular and Cellular PharmacologyUniversity of Copenhagen\, Denmark \n\n\n\nThe Pless lab is interested in the molecular function and pharmacology of ion channels. These complex membrane proteins regulate cellular excitability by controlling the flux of ions across cell membranes in response to a diverse set of stimuli. Their dysfunction is associated with numerous diseases\, resulting in an ever-increasing demand for new drugs targeting these fascinating molecules. \n\n\n\n\n\n\n\nDownload
URL:https://www.scilifelab.se/event/the-curious-case-of-a-leak-channel-that-never-wants-to-be-open/
LOCATION:Air&Fire\, SciLifeLab Stockholm\, Tomtebodavägen 23A\, Solna\, Sweden
CATEGORIES:Event
ATTACH;FMTTYPE=image/png:https://www.scilifelab.se/wp-content/uploads/2021/11/Skärmavbild-2021-11-02-kl.-16.27.31.png
ORGANIZER;CN="Molecular Biophysics Stockholm":MAILTO:join-mbp@scilifelab.se.
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20211109T150000
DTEND;TZID=Europe/Stockholm:20211109T160000
DTSTAMP:20260404T183112
CREATED:20211101T085537Z
LAST-MODIFIED:20211101T085648Z
UID:10000476-1636470000-1636473600@www.scilifelab.se
SUMMARY:Insights into EMBO’s Fellowship Programme
DESCRIPTION:Kelly Sheehan-Rooney\, Head of the Fellowship Programme at EMBO\, will give an overview of the eligibility and evaluation criteria of EMBO’s Postdoctoral Fellowships\, Scientific Exchange Grants\, and the New Venture Fellowships. She will also give some top tips for grant writing\, and an insight into her career move from academic research to international research development. \n\n\n\nKelly Sheehan-Rooney is Head of the Fellowship Programme at EMBO. She obtained her PhD in Developmental Biology from the University of Manchester\, UK\, before carrying out a three-year postdoctoral position at the University of Texas in Austin\, USA. Now with 10 years’ experience in international research development\, Kelly has worked with thousands of scientists across the world; supporting them in their various careers\, building collaborative networks\, and fostering a research environment where scientists can achieve their best work. \n\n\n\nResearchers in all stages of their career are welcome to attend and could find the talk useful. The fellowships are a great opportunity for early-stage researchers as well as for group leaders to further their research interests and consider new avenues to expand into high quality research ideas. \n\n\n\nMeeting Flyer
URL:https://www.scilifelab.se/event/insights-into-embos-fellowship-programme/
LOCATION:Online event via Zoom
CATEGORIES:Event
ORGANIZER;CN="SciLifeLab Solna PhD & Postdoc Council":MAILTO:phd-council@scilifelab.se
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20211110T140000
DTEND;TZID=Europe/Stockholm:20211110T150000
DTSTAMP:20260404T183112
CREATED:20211014T151000Z
LAST-MODIFIED:20211020T130718Z
UID:10000466-1636552800-1636556400@www.scilifelab.se
SUMMARY:[Drug Discovery Seminar] How protein degradation led to faculty entrepreneurship at Yale: A personal Perspective
DESCRIPTION:SciLifeLab Drug Discovery Seminars\, hosted by the DDD platform\, is a series of educational lectures about recent developments\, technologies\, and trends in drug discovery and development that aims to enlighten\, and spark a discussion\, within the Swedish drug discovery community. \n\n\n\nCraig Crews\n\n\n\n\n\n\n\n \n\n\n\nJohn C. Malone Professor of Molecular\, Cellular\, and Developmental Biology and Professor of Chemistry\, of Pharmacology\, and of Management; Executive Dirictor\, Yale Center for Molecular Discovery\, Yale University \n\n\n\nAbstract \n\n\n\nProf. Crews is the 2021 recipient of the Scheele prize from the Swedish Pharmaceutical Society for his seminal work on protein degradation. In this talk Prof. Crews will discuss his efforts to translate research from his lab into new biopharma ventures.  To date\, these entrepreneurial  efforts have resulted in a FDA approved drug (Kyprolis) and a new therapeutic modality (PROTACs).  While each of his four companies has been launched based on different science\, they have all followed a similar business model and Prof. Crews will discuss efforts at Yale to ’systematize’ faculty entrepreneurism via a core ‘biotech accelerator’ facility. \n\n\n\nregistration\n\n\n\nBiography \n\n\n\nCrews is the John C. Malone Professor of Molecular\, Cellular and Developmental Biology and holds joint appointments in the departments of Chemistry and Pharmacology at Yale University. He graduated from the U.Virginia with a B.A. in Chemistry and received his Ph.D. from Harvard University in Biochemistry. Dr. Crews has a foothold in both the academic and biotech arenas; on the faculty at Yale since 1995\, his laboratory has pioneered the use of small molecules to control intracellular protein levels.  \n\n\n\nIn 2003\, he co-founded Proteolix\, Inc.\, whose proteasome inhibitor\, Kyprolis™ received FDA approval for the treatment of multiple myeloma. Since Proteolix’s purchase by Onyx Pharmaceuticals in 2009\, Dr. Crews has focused on a new drug development technology\, which served as the founding intellectual property for his latest New Haven-based biotech venture\, Arvinas\, Inc.  \n\n\n\nCurrently\, Dr. Crews serves on several editorial boards and was Editor of Cell Chemical Biology (2008-2018). In addition\, he has received numerous awards and honors\, including the 2013 CURE Entrepreneur of the Year Award\, 2014 Ehrlich Award for Medicinal Chemistry\, 2015 Yale Cancer Center Translational Research Prize\, a NIH R35 Outstanding Investigator Award (2015)\, the AACR Award for Chemistry in Cancer Research (2017)\, Khorana Prize from the Royal Society of Chemistry (2018)\, Pierre Fabre Award for Therapeutic Innovation (2018)\, the Pharmacia-ASPET Award for Experimental Therapeutics (2019)\, the Heinrich Wieland Prize (2020) and the Scheele Prize (2021). In 2019\, he was named an American Cancer Society Professor.
URL:https://www.scilifelab.se/event/drug-discovery-seminar-faculty-entrepreneurship-at-yale-a-personal-perspective/
LOCATION:Air&Fire\, SciLifeLab Stockholm\, Tomtebodavägen 23A\, Solna\, Sweden
CATEGORIES:Event
END:VEVENT
END:VCALENDAR